Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Thomas Otto, Lukas-Krankenhaus GmbH
ClinicalTrials.gov Identifier:
NCT01265940
First received: December 22, 2010
Last updated: October 9, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)